Efecto de los Fármacos para el control de hipertensión y diabetes tipo II el el movimiento dental: una revisión sistémica

Vista sencilla de ítem
dc.contributor.advisorJarpa Remaggi, Patricio Javier
dc.contributor.advisorCastellanos Domínguez, Yeny Zulay
dc.contributor.authorAgudelo Solano, María José
dc.contributor.authorDelgado Jaimes, Ronald Yair
dc.contributor.authorEstupiñan Alarcón, Jhon Alexander
dc.contributor.authorVivas Flórez, Jairo Alberto
dc.date.accessioned2025-08-13T15:19:22Z
dc.date.available2025-08-13T15:19:22Z
dc.date.issued2025-08-12
dc.descriptionIntroducción: La prevalencia de diabetes e hipertensión plantea desafíos en ortodoncia debido a la potencial alteración del movimiento dental ortodóncico (O.T.M) por los medicamentos utilizados para su control. La necesidad de comprender integralmente esta interacción y la limitación de realizar un estudio primario motivó la realización de una revisión sistemática. Objetivo: identificar el efecto de los fármacos para la hipertensión y la diabetes en el movimiento dental ortodóncico, según la evidencia publicada en los últimos diez años. Materiales y métodos: Se realizó una revisión sistemática siguiendo la metodología PRISMA. Se buscaron artículos entre 2014 y 2024 en cinco bases de datos, gestionados con Mendeley y seleccionados en dos etapas cegadas por revisores mediante título/resumen y texto completo (con Rayyan). La calidad metodológica se evaluó con la herramienta JBI. La investigación se clasificó sin riesgo, respetando la propiedad intelectual, conforme a la Ley 1915 de 2018 y la 1032 de 2006. Resultados: De 1834 artículos, se incluyeron 10 estudios (60% de Google Scholar, 100% en inglés, 40% de Japón). Los estudios, con experimentación de 3 a 21 días, analizaron principalmente fármacos para diabetes (60%) e hipertensión (40%). En diabetes, la condición no controlada aumentó el O.T.M, mientras que insulina, metformina, IGF-1, exendina-4 y la proteína quinasa activada por monofosfato de adenosina tendieron a normalizarlo; la linagliptina lo inhibió. En hipertensión, el captopril aumentó el O.T.M, mientras que losartán (después de 12 días), butoxamina y propanolol lo redujeron. Conclusión: En pacientes diabéticos, insulina, metformina, IGF-1 y exendina-4 favorecen el O.T.M, mientras que la linagliptina lo inhibe. En hipertensos, el captopril lo aumenta, y losartán, propanolol y butoxamina lo disminuyen. Sin embargo, la necesidad de estudios clínicos en humanos es crucial para confirmar cómo estos medicamentos afectan el tratamiento ortodóncico en pacientes con enfermedades concurrentes, permitiendo así establecer guías de práctica clínica confiables.
dc.description.abstractIntroduction:The prevalence of diabetes and hypertension poses challenges in orthodontics due to the potential alteration of orthodontic tooth movement (OTM) by medications used for their control. The need for a comprehensive understanding of this interaction and the limitations in conducting a primary study motivated the completion of a systematic review. Objective: To identify the effect of medications for hypertension and diabetes on orthodontic tooth movement, based on evidence published over the last ten years. Materials and Methods: A systematic review was conducted following the PRISMA methodology. Articles published between 2014 and 2024 were searched across five databases, managed with Mendeley, and selected in two blinded stages by reviewers—first by title/abstract and then by full text (using Rayyan). Methodological quality was assessed using the JBI tool. The research was classified as risk-free, respecting intellectual property in accordance with Law 1915 of 2018 and Law 1032 of 2006. Results: Out of 1,834 articles, 10 studies were included (60% from Google Scholar, 100% in English, 40% from Japan). The studies, with experimental durations ranging from 3 to 21 days, mainly analyzed drugs for diabetes (60%) and hypertension (40%). In diabetes, the uncontrolled condition increased OTM, while insulin, metformin, IGF-1, exendin-4, and AMP-activated protein kinase tended to normalize it; linagliptin inhibited it. In hypertension, captopril increased OTM, while losartan (after 12 days), butoxamine, and propranolol reduced it. Conclusion: In diabetic patients, insulin, metformin, IGF-1, and exendin-4 promote OTM, while linagliptin inhibits it. In hypertensive patients, captopril increases OTM, whereas losartan, propranolol, and butoxamine decrease it. However, clinical studies in humans are essential to confirm how these medications affect orthodontic treatment in patients with comorbidities, thereby enabling the establishment of reliable clinical practice guidelines.
dc.description.degreelevelEspecializaciónspa
dc.description.degreenameEspecialista en Ortodonciaspa
dc.description.domainhttps://www.ustabuca.edu.co/
dc.format.mimetypeapplication/pdf
dc.identifier.citationAgudelos Solano, M.J., Delgado Jaimes, R.Y., Estupiñan Alarcón, J. A. y Vivas Florez, J. A.(2025)Introduction:The prevalence of diabetes and hypertension poses challenges in orthodontics due to the potential alteration of orthodontic tooth movement (OTM) by medications used for their control. The need for a comprehensive understanding of this interaction and the limitations in conducting a primary study motivated the completion of a systematic review. Objective: To identify the effect of medications for hypertension and diabetes on orthodontic tooth movement, based on evidence published over the last ten years. Materials and Methods: A systematic review was conducted following the PRISMA methodology. Articles published between 2014 and 2024 were searched across five databases, managed with Mendeley, and selected in two blinded stages by reviewers—first by title/abstract and then by full text (using Rayyan). Methodological quality was assessed using the JBI tool. The research was classified as risk-free, respecting intellectual property in accordance with Law 1915 of 2018 and Law 1032 of 2006. Results: Out of 1,834 articles, 10 studies were included (60% from Google Scholar, 100% in English, 40% from Japan). The studies, with experimental durations ranging from 3 to 21 days, mainly analyzed drugs for diabetes (60%) and hypertension (40%). In diabetes, the uncontrolled condition increased OTM, while insulin, metformin, IGF-1, exendin-4, and AMP-activated protein kinase tended to normalize it; linagliptin inhibited it. In hypertension, captopril increased OTM, while losartan (after 12 days), butoxamine, and propranolol reduced it. Conclusion: In diabetic patients, insulin, metformin, IGF-1, and exendin-4 promote OTM, while linagliptin inhibits it. In hypertensive patients, captopril increases OTM, whereas losartan, propranolol, and butoxamine decrease it. However, clinical studies in humans are essential to confirm how these medications affect orthodontic treatment in patients with comorbidities, thereby enabling the establishment of reliable clinical practice guidelines.[Tesis de posgrado]. Universidad Santo Tomas, Bucaramanga, colombia.
dc.identifier.instnameinstname:Universidad Santo Tomásspa
dc.identifier.reponamereponame:Repositorio Institucional Universidad Santo Tomásspa
dc.identifier.repourlrepourl:https://repository.usta.edu.cospa
dc.identifier.urihttp://hdl.handle.net/11634/69023
dc.language.isospa
dc.publisherUniversidad Santo Tomásspa
dc.publisher.branchCRAI-USTA Bucaramanga
dc.publisher.facultyFacultad de Odontologíaspa
dc.publisher.programEspecialización Ortodonciaspa
dc.relation.referencesBaghban Taraghdari, Z., Imani, R., & Mohabatpour, F. (2019). A Review on Bioengineering Approaches to Insulin Delivery: A Pharmaceutical and Engineering Perspective. In Macromolecular Bioscience (Vol. 19, Issue 4). Wiley-VCH Verlag. https://doi.org/10.1002/mabi.201800458
dc.relation.referencesBailey, C., & Day, C. (2003). Antidiabetic drugs. In Article in British Journal of Cardiology (Vol. 10). https://www.researchgate.net/publication/287869190
dc.relation.referencesBarker, T. H., Stone, J. C., Sears, K., Klugar, M., Leonardi-Bee, J., Tufanaru, C., Aromataris, E., & Munn, Z. (2023). Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evidence Synthesis, 21(3), 478–493. https://doi.org/10.11124/JBIES-22-00125
dc.relation.referencesBartzela, T., Türp, J. C., Motschall, E., & Maltha, J. C. (2009). Medication effects on the rate of orthodontic tooth movement: A systematic literature review. In American Journal of Orthodontics and Dentofacial Orthopedics (Vol. 135, Issue 1, pp. 16–26). https://doi.org/10.1016/j.ajodo.2008.08.016
dc.relation.referencesBösenberg, L. H., & Van Zyl, D. G. (2008). The mechanism of action of oral antidiabetic drugs: A review of recent literature. In Journal of Endocrinology, Metabolism and Diabetes of South Africa (Vol. 13, Issue 3, pp. 80–89). South African Medical Association. https://doi.org/10.1080/22201009.2008.10872177
dc.relation.referencesBuitrago-Gómez, N., Campo-Rivera, N., Figueroa-Torregroza, L., & Casanova-Valderrama, M. E. (2022). Hipertensión arterial esencial: ¿cuál agente antihipertensivo elegir? Salud UIS, 54(1). https://doi.org/10.18273/saluduis.54.e:22024
dc.relation.referencesCampins, L., Serra-Prat, M., Palomera, E., Bolibar, I., Martínez, M. À., & Gallo, P. (2019). Reduction of pharmaceutical expenditure by a drug appropriateness intervention in polymedicated elderly subjects in Catalonia (Spain). Gaceta Sanitaria, 33(2), 106–111. https://doi.org/10.1016/j.gaceta.2017.09.002
dc.relation.referencesCastro Serna, D., Guadalupe, M., & Martínez, C. (2006). Medicina Interna de México Volumen 22, Núm. 5, septiembre-octubre. www.revistasmedicasmexicanas.com.mx
dc.relation.referencesCiancio, S. G. (2004). Medications’ impact on oral health. Journal of the American Dental Association, 135(10), 1440–1448. https://doi.org/10.14219/jada.archive.2004.0055
dc.relation.referencesDavidovitch, Z. (1991). Tooth Movement. Critical Reviews in Oral Biology & Medicine, 2(4), 411–450. https://doi.org/10.1177/10454411910020040101
dc.relation.referencesDe Oliveira, E. L., Freitas, F. F., De Macedo, C. G., Clemente-Napimoga, J. T., Silva, M. B. F., Manhães-Jr, L. R. C., Junqueira, J. L. C., & Napimoga, M. H. (2014). Low dose propranolol decreases orthodontic movement. Archives of Oral Biology, 59(10), 1094–1100. https://doi.org/10.1016/j.archoralbio.2014.06.006
dc.relation.referencesDiravidamani, K., Sivalingam, S., & Agarwal, V. (2012). Drugs influencing orthodontic tooth movement: An overall review. Journal of Pharmacy
dc.relation.referencesdu Sert, N. P., Hurst, V., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., Garner, P., Holgate, S. T., Howells, D. W., Karp, N. A., Lazic, S. E., Lidster, K., MacCallum, C. J., Macleod, M., … Würbel, H. (2020). The arrive guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biology, 18(7). https://doi.org/10.1371/journal.pbio.3000410
dc.relation.referencesGarcía-Peñalvo, F. J. (2022a). Desarrollo de estados de la cuestión robustos: Revisiones Sistemáticas de Literatura. Education
dc.relation.referencesGarcía-Peñalvo, F. J. (2022b). Developing robust state-of-the-art reports: Systematic Literature Reviews. In Education in the Knowledge Society (Vol. 23, p. E28600). Ediciones Universidad de Salamanca. https://doi.org/10.14201/eks.28600
dc.relation.referencesGarlet, T. P., Coelho, U., Repeke, C. E., Silva, J. S., Cunha, F. de Q., & Garlet, G. P. (2008a). Differential expression of osteoblast and osteoclast chemmoatractants in compression and tension sides during orthodontic movement. Cytokine, 42(3), 330–335. https://doi.org/10.1016/j.cyto.2008.03.003
dc.relation.referencesGarlet, T. P., Coelho, U., Repeke, C. E., Silva, J. S., Cunha, F. de Q., & Garlet, G. P. (2008b). Differential expression of osteoblast and osteoclast chemmoatractants in compression and tension sides during orthodontic movement. Cytokine, 42(3), 330–335. https://doi.org/10.1016/j.cyto.2008.03.003
dc.relation.referencesGiles, T. D., Materson, B. J., Cohn, J. N., & Kostis, J. B. (2009). Definition and classification of hypertension: An update. In Journal of Clinical Hypertension (Vol. 11, Issue 11, pp. 611–614). https://doi.org/10.1111/j.1751-7176.2009.00179.x
dc.relation.referencesGonzález Peña, O. I., López Zavala, M. Á., & Cabral Ruelas, H. (2021). Pharmaceuticals Market, Consumption Trends and Disease Incidence Are Not Driving the Pharmaceutical Research on Water and Wastewater. International Journal of Environmental Research and Public Health, 18(5), 2532. https://doi.org/10.3390/ijerph18052532
dc.relation.referencesHales, C. M., Kit, B. K., Gu, Q., & Ogden, C. L. (2018). Trends in Prescription Medication Use Among Children and Adolescents—United States, 1999-2014. JAMA, 319(19), 2009. https://doi.org/10.1001/jama.2018.5690
dc.relation.referencesHuang, D., Li, Y., Chen, S., Wang, H., Jiang, Y., Wei, Y., Lin, H., & Zou, S. (2023). The onset of adenosine monophosphate-activated protein kinase activity on orthodontic tooth movement in rats with type 2 diabetes. European Journal of Oral Sciences, 131(5–6). https://doi.org/10.1111/eos.12955
dc.relation.referencesJackson, R. E., & Bellamy, M. C. (2015). Antihypertensive drugs. BJA Education, 15(6), 280–285. https://doi.org/10.1093/bjaceaccp/mku061
dc.relation.referencesKrishnan Davidovitch, V. Z., Krishnan, V., & -Krishnan, A. V. (n.d.). The effect of drugs on orthodontic tooth movement Structured Abstract.
dc.relation.referencesLaura, E. E. M., Cestari, T. M., Almeida, R., Pereira, D. S., Taga, R., Garlet, G. P., & Assis, G. F. (2019). Metformin as an add-on to insulin improves periodontal response during orthodontic tooth movement in type 1 diabetic rats. Journal of Periodontology, 90(8), 920–931. https://doi.org/10.1002/JPER.18-0140
dc.relation.referencesLaurent, S. (2017). Antihypertensive drugs. In Pharmacological Research (Vol. 124, pp. 116–125). Academic Press. https://doi.org/10.1016/j.phrs.2017.07.026 lehmann1995. (n.d.).
dc.relation.referencesLi, Y., Jacox, L. A., Little, S. H., & Ko, C. (2018). Orthodontic tooth movement: The biology and clinical implications. The Kaohsiung Journal of Medical Sciences, 34(4), 207–214. https://doi.org/10.1016/j.kjms.2018.01.007
dc.relation.referencesLi, Y., Zhan, Q., Bao, M., Yi, J., & Li, Y. (2021a). Biomechanical and biological responses of periodontium in orthodontic tooth movement: up-date in a new decade. In International Journal of Oral Science (Vol. 13, Issue 1). Springer Nature. https://doi.org/10.1038/s41368-021-00125-5
dc.relation.referencesLi, Y., Zhan, Q., Bao, M., Yi, J., & Li, Y. (2021b). Biomechanical and biological responses of periodontium in orthodontic tooth movement: up-date in a new decade. International Journal of Oral Science, 13(1), 20. https://doi.org/10.1038/s41368-021-00125-5
dc.relation.referencesMakrygiannakis, M. A., Kaklamanos, E. G., & Athanasiou, A. E. (2018). Does common prescription medication affect the rate of orthodontic tooth movement? A systematic review. European Journal of Orthodontics, 40(6), 649–659. https://doi.org/10.1093/ejo/cjy001
dc.relation.referencesMaltha, J. C., & Kuijpers-Jagtman, A. M. (2023). Mechanobiology of orthodontic tooth movement: An update. Journal of the World Federation of Orthodontists, 12(4), 156–160. https://doi.org/10.1016/j.ejwf.2023.05.001
dc.relation.referencesManterola, C., Astudillo, P., Arias, E., & Claros, N. (2013). Revisiones sistemáticas de la literatura. Qué se debe saber acerca de ellas. Cirugia Espanola, 91(3), 149–155. https://doi.org/10.1016/j.ciresp.2011.07.009
dc.relation.referencesMatthews, F., & Cartes-Velásquez, R. (n.d.). Factors that influence therapeutic decisions in Orthodontics: a literature review Therapeutic decisions in Orthodontics.
dc.relation.referencesMena, E., Cestari, T. M., Almeida, R., Pereira, D. S., Taga, R., Garlet, G. P., & Assis, G. F. (2019). Metformin as an add-on to insulin improves periodontal response during orthodontic tooth movement in type 1 diabetic rats. Journal of Periodontology, 90(8), 920–931. https://doi.org/10.1002/JPER.18-0140
dc.relation.referencesMesserli, F. H., Williams, B., & Ritz, E. (2007). Essential hypertension. In www.thelancet.com (Vol. 370). www.thelancet.com
dc.relation.referencesMirhashemi, A. H., Ahmad Akhoundi, M. S., Ansari, E., Sheikhzadeh, S., Momeni, N., Dehpour, A., Etemad-Moghadam, S., Kheirandish, Y., & Farhadifard, H. (2016). Effect of Long-Term Captopril Administration on Bone Density and Orthodontic Tooth Movement. Journal of Islamic Dental Association of IRAN, 28(4), 126–133. https://doi.org/10.30699/jidai.29.4.126
dc.relation.referencesMoelands, S. V. L., Lucassen, P. L. B. J., Akkermans, R. P., De Grauw, W. J. C., & Van de Laar, F. A. (2018). Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. In Cochrane Database of Systematic Reviews (Vol. 2018, Issue 12). John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD005061.pub3
dc.relation.referencesMoura, A. P., Montalvany-Antonucci, C. C., Taddei, S. R. D. A., Queiroz-Junior, C. M., Biguetti, C. C., Garlet, G. P., Ferreira, A. J., Teixeira, M. M., Silva, T. A., & Andrade, I. (2016). Effects of angiotensin II type i receptor blocker losartan on orthodontic tooth movement. American Journal of Orthodontics and Dentofacial Orthopedics, 149(3), 358–365. https://doi.org/10.1016/j.ajodo.2015.09.019
dc.relation.referencesNiño Charry, A. A., Valdez Javier, V., Wong, E., & Quirós, J. (2019). Revista Mexicana de Ortodoncia Factores que influyen en la alteración del movimiento ortodóntico. Revisión bibliográfica (Vol. 7). www.medigraphic.org.mx
dc.relation.referencesPeña, S. P., Arenas, M., Martin, S., González Elso, F., Rivas, A. H., & Palma Díaz, E. (n.d.). Influencia de la diabetes mellitus en el trata-miento ortodóncico. Revisión de la literatura Influence of diabetes mellitus in orthodontic treatment. A review of the literature.
dc.relation.referencesPetersmann, A., Müller-Wieland, D., Müller, U. A., Landgraf, R., Nauck, M., Freckmann, G., Heinemann, L., & Schleicher, E. (2019). Definition, Classification and Diagnosis of Diabetes Mellitus. Experimental and Clinical Endocrinology and Diabetes, 127, S1–S7. https://doi.org/10.1055/a-1018-9078
dc.relation.referencesPetersmann, A., Nauck, M., Müller-Wieland, D., Kerner, W., Müller, U. A., Landgraf, R., Freckmann, G., & Heinemann, L. (2018). Definition, Classification and Diagnosis of Diabetes Mellitus. Experimental and Clinical Endocrinology and Diabetes, 126(7), 406–410. https://doi.org/10.1055/a-0584-6223
dc.relation.referencesPollock, A., & Berge, E. (2018b). How to do a systematic review. In International Journal of Stroke (Vol. 13, Issue 2, pp. 138–156). SAGE Publications Inc. https://doi.org/10.1177/1747493017743796
dc.relation.referencesQi, J., Kitaura, H., Shen, W. R., Ogawa, S., Ohori, F., Noguchi, T., Marahleh, A., Nara, Y., Adya, P., & Mizoguchi, I. (2020). Effect of a DPP-4 Inhibitor on Orthodontic Tooth Movement and Associated Root Resorption. BioMed Research International, 2020. https://doi.org/10.1155/2020/7189084
dc.relation.referencesRevisión, T. DE, Niño Charry, A. A., Valdez Javier, V., Wong, E., & Quirós, J. (2019). Revista Mexicana de Ortodoncia Factores que influyen en la alteración del movimiento ortodóntico. Revisión bibliográfica (Vol. 7). www.medigraphic.org.mx
dc.relation.referencesRobertson, G. L. (1995). DIABETES INSIPIDUS. In Chicago Illinois ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA VOLUME (Vol. 24, Issue 3).
dc.relation.referencesRojas, D. E., Molina, D. R., & Rodríguez, C. (n.d.-a). CAPÍTULO II DEFINICIÓN, CLASIFICACIÓN Y DIAGNÓSTICO DE LA DIABETES MELLITUS.
dc.relation.referencesRojas, D. E., Molina, D. R., & Rodríguez, C. (n.d.-b). CAPÍTULO II DEFINICIÓN, CLASIFICACIÓN Y DIAGNÓSTICO DE LA DIABETES MELLITUS.
dc.relation.referencesSantiago, M., Davis, E. A., Hinton, T., Angelo, T. A., Shield, A., Babey, A. M., Kemp-Harper, B., Maynard, G., Al-Sallami, H. S., Musgrave, I. F., Fernandes, L. B., Ngo, S. N. T., Christopoulos, A., & White, P. J. (2021). Defining and unpacking the core concepts of pharmacology education. Pharmacology Research and Perspectives, 9(6). https://doi.org/10.1002/prp2.894
dc.relation.referencesSato, T., Miyazawa, K., Suzuki, Y., Mizutani, Y., Uchibori, S., Asaoka, R., Arai, M., Togari, A., & Goto, S. (2014a). Selective β2-adrenergic antagonist butoxamine reduces orthodontic tooth movement. Journal of Dental Research, 93(8), 807–812. https://doi.org/10.1177/0022034514536730
dc.relation.referencesSato, T., Miyazawa, K., Suzuki, Y., Mizutani, Y., Uchibori, S., Asaoka, R., Arai, M., Togari, A., & Goto, S. (2014b). Selective β2-adrenergic antagonist butoxamine reduces orthodontic tooth movement. Journal of Dental Research, 93(8), 807–812. https://doi.org/10.1177/0022034514536730
dc.relation.referencesShen, W. R., Kitaura, H., Qi, J., Ogawa, S., Ohori, F., Noguchi, T., Marahleh, A., Nara, Y., Adya, P., & Mizoguchi, I. (2021). Local administration of high-dose diabetes medicine exendin-4 inhibits orthodontic tooth movement in mice. Angle Orthodontist, 91(1), 111–118. https://doi.org/10.2319/021320-103.1
dc.relation.referencesSmith, R. J., & Burstone, C. J. (1984). Mechanics of tooth movement. American Journal of Orthodontics, 85(4), 294–307. https://doi.org/10.1016/0002-9416(84)90187-8
dc.relation.referencesSun, J., Du, J., Feng, W., Lu, B., Liu, H., Guo, J., Amizuka, N., & Li, M. (2017a). Histological evidence that metformin reverses the adverse effects of diabetes on orthodontic tooth movement in rats. Journal of Molecular Histology, 48(2), 73–81. https://doi.org/10.1007/s10735-016-9707-y
dc.relation.referencesSun, J., Du, J., Feng, W., Lu, B., Liu, H., Guo, J., Amizuka, N., & Li, M. (2017b). Histological evidence that metformin reverses the adverse effects of diabetes on orthodontic tooth movement in rats. Journal of Molecular Histology, 48(2), 73–81. https://doi.org/10.1007/s10735-016-9707-y
dc.relation.referencesTawfik, G. M., Dila, K. A. S., Mohamed, M. Y. F., Tam, D. N. H., Kien, N. D., Ahmed, A. M., & Huy, N. T. (2019). A step by step guide for conducting a systematic review and meta-analysis with simulation data. Tropical Medicine and Health, 47(1), 46. https://doi.org/10.1186/s41182-019-0165-6
dc.relation.referencesTortolini, P., & Fernández Bodereau, E. (2011). Ortodoncia y periodoncia. AVANCES EN ODONTOESTOMATOLOGÍA, 27(4), 197–206.
dc.relation.referencesToyama, N., Ono, T., Ono, T., & Nakashima, T. (2023). The interleukin-6 signal regulates orthodontic tooth movement and pain. Biochemical and Biophysical Research Communications, 684, 149068. https://doi.org/10.1016/j.bbrc.2023.09.096
dc.relation.referencesVargas-Uricoechea, H., & Casas-Figueroa, L. Á. (2015). An Epidemiologic Analysis of Diabetes in Colombia. In Annals of Global Health (Vol. 81, Issue 6, pp. 742–753). Elsevier USA. https://doi.org/10.1016/j.aogh.2015.11.001
dc.relation.referencesWang, M., Qiu, Y., Gao, L., Qi, F., & Bi, L. (2023). The impact of IGF-1 on alveolar bone remodeling and BMP-2 expression in orthodontic tooth movement in diabetic rats. Advances in Clinical and Experimental Medicine, 32(3), 349–356. https://doi.org/10.17219/acem/153956
dc.relation.referencesWaring, W. S. (2016). Antidiabetic drugs. In Medicine (United Kingdom) (Vol. 44, Issue 3, pp. 138–140). Elsevier Ltd. https://doi.org/10.1016/j.mpmed.2015.12.011
dc.relation.referencesZhou, B., Carrillo-Larco, R. M., Danaei, G., Riley, L. M., Paciorek, C. J., Stevens, G. A., Gregg, E. W., Bennett, J. E., Solomon, B., Singleton, R. K., Sophiea, M. K., Iurilli, M. L., Lhoste, V. P., Cowan, M. J., Savin, S., Woodward, M., Balanova, Y., Cifkova, R., Damasceno, A., … Ezzati, M. (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet, 398(10304), 957–980. https://doi.org/10.1016/S0140-6736(21)01330-1
dc.rightsAttribution-NonCommercial-NoDerivs 2.5 Colombiaen
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2
dc.rights.localAbierto (Texto Completo)spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.subject.keywordTooth movement
dc.subject.keywordOrthodontics
dc.subject.keywordHypertension
dc.subject.keywordDiabetes mellitus
dc.subject.keywordComorbidity
dc.subject.lembOdontología especializada
dc.subject.lembAnálisis de información
dc.subject.lembPacientes odontológicos
dc.subject.lembFármacos
dc.subject.proposalMovimiento
dc.subject.proposalOrtodoncia
dc.subject.proposalHipertensión
dc.subject.proposalDiabetes mellitus
dc.subject.proposalComorbilidad
dc.titleEfecto de los Fármacos para el control de hipertensión y diabetes tipo II el el movimiento dental: una revisión sistémica
dc.typebachelor thesis
dc.type.categoryFormación de Recurso Humano para la Ctel: Trabajo de grado de Especialización
dc.type.coarhttp://purl.org/coar/resource_type/c_7a1f
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.driveinfo:eu-repo/semantics/bachelorThesis
dc.type.localTrabajo de gradospa
dc.type.versioninfo:eu-repo/semantics/acceptedVersion

Archivos

Bloque original

Mostrando 1 - 3 de 3
Miniatura
Nombre:
2025mariaagudelo.pdf
Tamaño:
651.69 KB
Formato:
Adobe Portable Document Format
Descripción:
Trabajo de grado
Descargar
Miniatura
Nombre:
2025mariaagudelo1.pdf
Tamaño:
216.45 KB
Formato:
Adobe Portable Document Format
Descripción:
Carta de facultad
Descargar
Miniatura
Nombre:
2025mariaagudelo2.pdf
Tamaño:
8.54 MB
Formato:
Adobe Portable Document Format
Descripción:
Acuerdo de publicación
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
807 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Especialización Ortodoncia